Pharmacological characterization of mediators and vagal influence in the acute allergic bronchoconstriction in guinea pigs.
The allergic bronchoconstriction in guinea pigs has been attributed mainly to the release of mast cell mediators. Histamine has been involved in the first minutes of the anaphylactic reaction and new-formed compounds in the subsequent response. In this asthma model the vagal influence has been sparsely investigated. In the present work we evaluated the pharmacological modification of the acute allergic bronchoconstrictor response in guinea pigs sensitized to ovalbumin through aerosol exposure. Pyrilamine (20 micrograms/kg), diethylcarbamazine (a lipoxygenase inhibitor, 10 mg/kg) and dexamethasone (4 mg/kg) each reduced the antigen-induced bronchoconstriction throughout the 30 min studied. Indomethacin (3.1 mg/kg) did not modify the response to the antigen. Atropine (2 mg/kg) plus bilateral vagotomy also diminished this response from 5 min onward. On the other hand, from 5 min ahead pyrilamine-resistant bronchoconstriction was partially inhibited by dexamethasone, and it was almost completely blocked during all of the response when atropine plus bilateral vagotomy were added to dexamethasone. Dipyridamole (an inhibitor of the adenosine uptake, 0.4 mg/kg) enhanced the bronchoconstriction, though this was significant only in the 2-5 min time-interval of the response. These results suggest that histamine and vagal influence play an important role in the whole response to antigen, that other mediators, probably leukotrienes, participate in this response from 5 min onward, and that adenosine could exert a potentiation effect on this response.
Vargas
M H
MH
Unidad de Investigación, Instituto Nacional de Enfermedades Respiratorias, México, D.F.
Montaño
L M
LM
Vanda
B
B
Segura
P
P
Selman
M
M
D000241:Adenosine / Q000502:physiology; D000818:Animals; D016084:Bronchoconstriction / Q000502:physiology*; D003907:Dexamethasone / Q000494:pharmacology; D004049:Diethylcarbamazine / Q000494:pharmacology; D004176:Dipyridamole / Q000494:pharmacology; D004537:Eicosanoic Acids / Q000494:pharmacology; D005260:Female; D006168:Guinea Pigs; D006632:Histamine / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D008297:Male; D009434:Neural Pathways / Q000187:drug effects / Q000502:physiology; D010047:Ovalbumin / Q000276:immunology; D011738:Pyrilamine / Q000494:pharmacology; D012130:Respiratory Hypersensitivity / Q000503:physiopathology*; D014628:Vagotomy; D014630:Vagus Nerve / Q000502:physiology*
D004537:Eicosanoic Acids; D004176:Dipyridamole; D003907:Dexamethasone; D006632:Histamine; D010047:Ovalbumin; D011738:Pyrilamine; D000241:Adenosine; D004049:Diethylcarbamazine; D007213:Indomethacin